(Q48344243)

English

Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness.

scientific article published in December 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

5

object named as

P Cumming

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

author name string

G Léger

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

H Kuwabara

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

M Guttman

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

30

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

351-361

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Potentiation of the l-Dopa effect in man by the use of catechol-O-methyltransferase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

MRI-PET correlation in three dimensions using a volume-of-interest (VOI) atlas.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Striatal dopamine metabolism in living monkeys examined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Dopa decarboxylase activity of the living human brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

18F‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Nigrostriatal function in humans studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-dopa

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Differential effects of ketamine and pentobarbitone on acetylcholine release from the rat hippocampus and striatum.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199812%2930%3A4%3C351%3A%3AAID-SYN2%3E3.0.CO%3B2-2

21 January 2018

Identifiers

10.1002/(SICI)1098-2396(199812)30:4<351::AID-SYN2>3.0.CO;2-2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9826227

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48344243&oldid=1421652312"